The cannabis landscape is changing fast, and keeping up with the headlines isn't always easy.
In this solo edition of Let's Be Blunt with Montel, Montel breaks down the biggest developments in cannabis policy, industry news, global markets, and scientific research—and what they mean for consumers, patients, and businesses.
With major changes to federal hemp regulations approaching, questions surrounding marijuana rescheduling, and new research challenging long-held assumptions about cannabis, there's plenty to unpack.
In this episode, Montel covers:
- The Federal Hemp Countdown: How upcoming changes to federal hemp law could reshape the CBD and hemp-derived THC markets, and why retailers and consumers should pay attention.
- Marijuana Rescheduling: Where federal cannabis policy really stands, what Schedule III means, and why rescheduling isn't the same as legalization.
- The Business of Cannabis: Industry consolidation, regulatory challenges, taxation, and the growing tension between licensed marijuana businesses and hemp-derived THC products.
- Cannabis Around the World: Major developments in Germany, the United Kingdom, and Thailand—and what their different approaches reveal about the future of cannabis regulation.
- The Latest Cannabis Science: New findings involving chronic pain, cognition, stress, migraines, and driving impairment.
- Montel's Watch List: Five important developments to follow as the cannabis landscape continues to evolve.
Drawing on decades of advocacy for medical cannabis patients and responsible reform, Montel cuts through the noise to ask a fundamental question: Are we finally moving toward sensible, science-based cannabis policy, or creating even more confusion?
Whether you're a patient, consumer, cannabis industry professional, or simply curious about where cannabis is headed, this is a conversation worth hearing.
Subscribe to Let's Be Blunt with Montel for candid conversations, expert perspectives, and the latest developments shaping the future of cannabis.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
